Related Experiment Video
Updated: May 18, 2026

Artificial RNA Polymerase II Elongation Complexes for Dissecting Co-transcriptional RNA Processing Events
Published on: May 13, 2019
Carbon monoxide releasing molecule-2 CORM-2 represses global protein synthesis by inhibition of eukaryotic elongation
Christian Ingo Schwer1, Patrick Stoll, Sabine Rospert
1Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Hugstetterstrasse 55, D-79106 Freiburg, Germany. christian.schwer@uniklinik-freiburg.de
Abstract:
Carbon monoxide (CO) is an endogenous gaseous transmitter that exerts antiproliferative effects in many cell types, but effects of CO on the translational machinery are not described. We examined the effects of the carbon monoxide releasing molecule-2 (CORM-2) on critical steps in translational signaling and global protein synthesis in pancreatic stellate cells (PSCs), the most prominent collagen-producing cells in the pancreas, whose activation is associated with pancreatic fibrosis. PSCs were isolated from rat pancreatic tissue and incubated with CORM-2. CORM-2 prevented the decrease in the phosphorylation of eukaryotic elongation factor 2 (eEF2) caused by serum. By contrast, the activation dependent phosphorylation of initiation factor 4E-binding protein 1 (4E-BP1) was inhibited by CORM-2 treatment. The phosphorylation of eukaryotic initiation factor 2α (eIF2α) and eukaryotic initiation factor 4E (eIF4E) were not affected by CORM-2 treatment. In consequence, CORM-2 mediated eEF2 phosphorylation and inactivation of 4E-BP1 suppressed global protein synthesis. These observations were associated with inhibition of phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling and increased intracellular calcium and cAMP levels. The CORM-2 mediated inhibition of protein synthesis resulted in downregulation of cyclin D1 and cyclin E expression, a subsequent decline in the phosphorylation of the retinoblastoma tumor suppressor protein (Rb) and cell growth arrest at the G(0)/G(1) phase checkpoint of the cell cycle. Our results suggest the therapeutic application of CO releasing molecules such as CORM-2 for the treatment of fibrosis, inflammation, cancer, or other pathologic states associated with excessive protein synthesis or hyperproliferation. However, prolonged exogenous application of CO might also have negative effects on cellular protein homeostasis.
Insights
Carbon monoxide (CO) releasing molecule-2 (CORM-2) inhibits global protein synthesis in pancreatic stellate cells by affecting key translational factors. This suggests therapeutic potential for CO-based therapies in fibrotic and hyperproliferative diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Pharmacology
Background:
- Carbon monoxide (CO) is an endogenous gaseous transmitter with known antiproliferative effects.
- The impact of CO on cellular translational machinery, particularly in pancreatic stellate cells (PSCs), remains largely undescribed.
- PSCs are key collagen-producing cells implicated in pancreatic fibrosis.
Purpose of the Study:
- To investigate the effects of the CO-releasing molecule-2 (CORM-2) on translational signaling and protein synthesis in PSCs.
- To elucidate the molecular mechanisms underlying CORM-2's impact on PSCs.
- To explore the therapeutic potential of CORM-2 in conditions involving excessive protein synthesis or hyperproliferation.
Main Methods:
- Isolation and incubation of rat PSCs with CORM-2.
- Assessment of phosphorylation status of key translational factors including eukaryotic elongation factor 2 (eEF2), 4E-binding protein 1 (4E-BP1), eukaryotic initiation factor 2α (eIF2α), and eukaryotic initiation factor 4E (eIF4E).
- Analysis of phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway, intracellular calcium and cAMP levels, cell cycle regulatory proteins (cyclin D1, cyclin E, retinoblastoma protein Rb), and global protein synthesis.
Main Results:
- CORM-2 prevented serum-induced decrease in eEF2 phosphorylation but inhibited 4E-BP1 phosphorylation.
- CORM-2 treatment suppressed global protein synthesis in PSCs.
- These effects were linked to inhibition of PI3K-Akt-mTOR signaling, increased intracellular calcium and cAMP, downregulation of cyclins D1 and E, and cell cycle arrest at G(0)/G(1) phase.
Conclusions:
- CORM-2 modulates critical steps in translational signaling, leading to suppressed protein synthesis and cell growth arrest in PSCs.
- CO releasing molecules like CORM-2 show promise for treating fibrosis, inflammation, cancer, and other pathologies characterized by excessive protein synthesis or hyperproliferation.
- Prolonged exogenous CO application may pose risks to cellular protein homeostasis.
Related Concept Videos
Stringent Response in E. coli
Regulation of Expression at Multiple Steps
Transcriptional Regulation: Riboswitches
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors

